Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-000909

Mirati Therapeutics, Inc. · MRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 8, 2019
Accepted (ET)
Jan 9, 2019 · 9:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF3,F1,F2Jan 8, 2019S150,000$50.70D1,415,560D
Common StockF4,F1,F2Jan 8, 2019S123,800$51.56D1,291,760D
Common StockF5,F1,F2Jan 8, 2019S233,303$52.88D1,058,457D
Common StockF6,F1,F2Jan 8, 2019S42,897$54.36D1,015,560D
Common StockF1,F2Jan 8, 2019F12$48.28D1,015,548D
Common StockF1,F2Jan 8, 2019M550,012$0.001A1,565,560D
Common StockF7,F1,F2Jan 9, 2019S20,000$50.21D1,545,560D
Common StockF8,F1,F2Jan 9, 2019S80,000$51.43D1,465,560D
Common StockF9,F1,F2Jan 9, 2019S50,000$52.27D1,415,560D
Common StockF1,F2Jan 9, 2019F3$50.89D1,415,557D
Common StockF1,F2Jan 9, 2019M150,003$0.001A1,565,560D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to purchase)F1,F2,F10$0.001Jan 8, 2019M550,012DJan 6, 2017—Common Stock550,0121,791,774D
Warrant (right to purchase)F1,F2,F10$0.001Jan 9, 2019M150,003DJan 6, 2017—Common Stock150,0031,641,771D

Explanation of responses